Last updated on August 2017

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials


Brief description of study

This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.

Clinical Study Identifier: NCT02918539

Contact Investigators or Research Sites near you

Start Over

Avid Clinical Operations

Lovelance Scientific Resources, Inc.
Venice, FL United States
5.4miles
  Connect »